Company / Financials
CANNAPHARMARX, INC. Financials
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.4M
FY2025 · +66.1% YoY
Net Income
-$11.1M
FY2025 · -12.4% YoY
Profit Margin
-817.2%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$7.0M
FY2025
Total Debt
-
FY2025
Equity
-$30.2M
FY2025
ROA
-158.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.4M+66.1% YoYNet Income HistoryProfit after all expenses and taxes-$11.1M-12.4% YoYGross Profit HistoryRevenue minus cost of goods sold-$2.1M+29.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$3.4M-8.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$3.3M+7.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$489.6K+319.8% YoYR&D Expense HistoryResearch and development spending$324.1KInterest Expense HistoryCost of borrowing and debt obligations$2.0M-13.5% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share$0.12